Jun 11, 2019 / 09:00PM GMT
Chris Cooper - Goldman Sachs Group Inc., Research Division - Research Analyst
Okay. Good. I think in the interest of time we'll make a start. Welcome, again, to day 1 of the Goldman Sachs Global Healthcare Conference. My name is Chris Cooper. I'm a health care analyst here at Goldman Sachs. It gives me a great pleasure to introduce Penumbra. So look, I don't know if you guys want to start with maybe just an introductory line or 2 or we can just go straight into it.
Adam Elsesser - Penumbra, Inc. - Co Founder, Chairman, CEO & President
Why don't we get straight into it?
Questions and Answers:
Chris Cooper - Goldman Sachs Group Inc., Research Division - Research AnalystSure. Absolutely. So look, I mean, maybe we can just make a start on product portfolio. I know you've launched a couple of new products with JET 7 last year. Can you just give us an update on how that's going, please?
Adam Elsesser - Penumbra, Inc. - Co Founder, Chairman, CEO & President
So just
Trustpilot
